MCVEF OTC
Medicover AB (publ)
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +117.0%
5Y: -10.3%
$27.25
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$344M
+31.2% ▲
5Y CAGR: +17.1%
Capital Expenditures
$158M
-29.3% ▼
5Y CAGR: +16.9%
Free Cash Flow
$186M
+33.0% ▲
5Y CAGR: +17.3%
Dividends Paid
$22M
-25.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$12M
-34.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $144M | $20M | $24M | $20M | $98M |
| Depreciation & Amort. | $111M | $162M | $187M | $215M | $215M |
| Stock-Based Comp. | $6M | $10M | $9M | $12M | $15M |
| Change in Working Capital | -$41M | -$40M | -$15M | -$18M | -$5M |
| Other Non-Cash Items | $17M | $34M | -$421K | $33M | $20M |
| Operating Cash Flow | $217M | $170M | $205M | $262M | $344M |
| — Investing Activities — | |||||
| Capital Expenditures | -$102M | -$141M | -$110M | -$122M | -$158M |
| Acquisitions (Net) | -$88M | -$229M | -$6M | -$18M | -$175M |
| Investment Purchases | -$184M | -$7M | -$21M | -$26M | -$16M |
| Investment Sales | $40M | $187M | $19M | $23M | $19M |
| Other Investing | $300K | $5M | -$2M | $8M | $8M |
| Investing Cash Flow | -$334M | -$185M | -$120M | -$135M | -$322M |
| — Financing Activities — | |||||
| Net Debt Issuance | $239M | $39M | -$900K | $130M | $171M |
| Stock Repurchased | -$300K | $0 | -$308K | $0 | $0 |
| Dividends Paid | -$10M | -$18M | -$18M | -$18M | -$22M |
| Other Financing | -$64M | -$45M | -$55M | -$220M | -$154M |
| Financing Cash Flow | $164M | -$24M | -$74M | -$108M | -$6M |
| Net Change in Cash | $35M | -$42M | $10M | $19M | $12M |
| Cash End of Period | $82M | $40M | $51M | $70M | $82M |
| Free Cash Flow | $114M | $30M | $94M | $140M | $186M |